A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase And

Total Page:16

File Type:pdf, Size:1020Kb

A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase And MOL #111849 A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and Cyclic AMP Signaling Monica Soto-Velasquez, Michael P. Hayes, Aktan Alpsoy, Emily C. Dykhuizen, and Val J. Watts Molecular Pharmacology SUPPLEMENTAL FIGURES Supplemental Table 1. Sequence of primers used for RT-qPCR 1 MOL #111849 SUPPLEMENTAL FIGURES A. B. Supplemental Figure 1. Relative mRNA levels of AC isoforms in HEK293, HEK-ACΔ6, and HEK-ACΔ3/6 cell lines determined by RT-qPCR. (A). Agarose gel electrophoresis of RT-qPCR products from total RNA isolated from HEK293 cells. (B). Fold-change in relative gene expression between HEK293 cells and the knockout cell lines. Data represents the mean and SEM of three biological replicates independently run and conducted in duplicate. Statistical analysis was performed using unpaired t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 compared ΔCt values of knockout cell line to the ΔCt values of the HEK293 parental cell line for each target gene. 2 MOL #111849 A. B. HEK-ACΔ6 cell line C. HEK-ACΔ3/6 cell line Supplemental Figure 2. Genotypic characterization of HEK-ACΔ6 and HEK-ACΔ3/6 cell lines Schematic for the generation and characterization of the CRISPR/Cas9-based cell lines (A). Genomic sequencing and predicted protein sequence alignment for the ADCY3 and/or ADCY6 edited genes in the HEK-ACΔ6 (B) and the HEK-ACΔ3/6 (C) cell lines. 3 MOL #111849 The sgRNA target sequences are in bold, and the black triangles indicate the Cas9- mediated cleavage site upstream of the protospacer adjacent motif (PAM) sequence (box). The resulting indels for the ADCY3 and/or ADCY6 genes were determined by sequencing a PCR product that contained the nuclease cleavage site from the genomic DNA of the clonal cell lines. The black arrows show the mutation (deletion/insertion) introduced for each allele of the targeted genes, and the deleted/inserted base pairs are underlined. These indels caused a frame-shift on both ADCY3 and ADCY6 genes that introduced a premature STOP codon as illustrated by the amino acid sequence alignment between wild-type ADCY3 or ADCY6 genes and the predicted protein sequences of the mutated genes. Amino acid sequence for the wild-type genes are in bold and aligned regions with 100% identity are shaded in grey. 4 MOL #111849 Supplemental Figure 3. Ca2+ inhibition of AC5 and AC6 activity. HEK-ACΔ3/6 cells transiently transfected with Venus, AC5, or AC6 were treated for 1- hour with 10 μM forskolin in the absence (black) or presence (white) of the Ca2+ ionophore, A23187, and cAMP accumulation was measured. Data represents the mean and SEM of four to five independent experiments conducted in duplicate. Statistical analysis was performed using paired t-test. *P < 0.05, **P < 0.01 compared to the cAMP levels of the vehicle-treated cells. 5 MOL #111849 Supplemental Figure 4. Ca2+ stimulation of AC1 mutants expressed in HEK293 and HEK-ACΔ3/6 cells. HEK293 and HEK-ACΔ3/6 cells transiently transfected with Venus, AC1-WT, or the AC1 mutant constructs were stimulated with 3 μM A23187 for 1-hour, and cAMP accumulation was measured. Data represents the mean and SEM of three independent experiments conducted in duplicate. 6 .
Recommended publications
  • Original Article Upregulation of HOXA13 As a Potential Tumorigenesis and Progression Promoter of LUSC Based on Qrt-PCR and Bioinformatics
    Int J Clin Exp Pathol 2017;10(10):10650-10665 www.ijcep.com /ISSN:1936-2625/IJCEP0065149 Original Article Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics Rui Zhang1*, Yun Deng1*, Yu Zhang1, Gao-Qiang Zhai1, Rong-Quan He2, Xiao-Hua Hu2, Dan-Ming Wei1, Zhen-Bo Feng1, Gang Chen1 Departments of 1Pathology, 2Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. *Equal contributors. Received September 7, 2017; Accepted September 29, 2017; Epub October 1, 2017; Published October 15, 2017 Abstract: In this study, we investigated the levels of homeobox A13 (HOXA13) and the mechanisms underlying the co-expressed genes of HOXA13 in lung squamous cancer (LUSC), the signaling pathways in which the co-ex- pressed genes of HOXA13 are involved and their functional roles in LUSC. The clinical significance of 23 paired LUSC tissues and adjacent non-tumor tissues were gathered. HOXA13 levels in LUSC were detected by quantita- tive real-time polymerase chain reaction (qRT-PCR). HOXA13 levels in LUSC from The Cancer Genome Atlas (TCGA) and Oncomine were analyzed. We performed receiver operator characteristic (ROC) curves of various clinicopath- ological features of LUSC. Co-expressed of HOXA13 were collected from MEM, cBioPortal and GEPIA. The func- tions and pathways of the most reliable overlapped genes were achieved from the Gene Otology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. The protein-protein interaction (PPI) net- works were mapped using STRING. HOXA13 in LUSC were markedly upregulated compared with those in the non- cancerous controls as demonstrated by qRT-PCR (LUSC: 0.330±0.360; CONTROLS: 0.155±0.142; P=0.021).
    [Show full text]
  • Adenylate Cyclase 3: a New Target for Anti‐Obesity Drug Development
    obesity reviews doi: 10.1111/obr.12430 Obesity Pharmacotherapy Adenylate cyclase 3: a new target for anti-obesity drug development L. Wu,1 C. Shen,2 M. Seed Ahmed,3 C.-G. Östenson4 and H. F. Gu5,6 1Jiangsu Key Laboratory of Drug Screening, Summary China Pharmaceutical University, Nanjing Obesity has become epidemic worldwide, and abdominal obesity has a negative im- 210009, China, 2Department of Epidemiology, pact on health. Current treatment options on obesity, however, still remain limited. School of Public Health, Nanjing Medical It is then of importance to find a new target for anti-obesity drug development University, Nanjing 211166, China, 3Unit for based upon recent molecular studies in obesity. Adenylate cyclase 3 (ADCY3) is Medical Education, Centre for Learning and the third member of adenylyl cyclase family and catalyses the synthesis of cAMP Knowledge, Department of Learning, from ATP. Genetic studies with candidate gene and genome-wide association study Informatics, Management and Ethics, approaches have demonstrated that ADCY3 genetic polymorphisms are associated Karolinska Institutet, Stockholm 17177, with obesity in European and Chinese populations. Epigenetic studies have indi- Sweden, 4Rolf Luft Center for Diabetes cated that increased DNA methylation levels in the ADCY3 gene are involved in Research and Endocrinology, Department of the pathogenesis of obesity. Furthermore, biological analyses with animal models Molecular Medicine and Surgery, Karolinska have implicated that ADCY3 dysfunction resulted in increased body weight and Institutet, Karolinska University Hospital, Solna, fat mass, while reduction of body weight is partially explained by ADCY3 activa- Stockholm 17176, Sweden, 5Department of tion. In this review, we describe genomic and biological features of ADCY3, sum- Clinical Science, Intervention and marize genetic and epigenetic association studies of the ADCY3 gene with obesity Technologies, Karolinska Institutet, Karolinska and discuss dysfunction and activation of ADCY3.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Increased Plasma Levels of Adenylate Cyclase 8 and Camp Are Associated with Obesity and Type 2 Diabetes: Results from a Cross-Sectional Study
    biology Article Increased Plasma Levels of Adenylate Cyclase 8 and cAMP Are Associated with Obesity and Type 2 Diabetes: Results from a Cross-Sectional Study 1, 2, , 2, 2 Samy M. Abdel-Halim y, Ashraf Al Madhoun * y , Rasheeba Nizam y, Motasem Melhem , Preethi Cherian 3, Irina Al-Khairi 3, Dania Haddad 2, Mohamed Abu-Farha 3 , Jehad Abubaker 3, Milad S. Bitar 4 and Fahd Al-Mulla 2,* 1 Department of Oncology, Karolinska University Hospital, 17177 Stockholm, Sweden; [email protected] 2 Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait; [email protected] (R.N.); [email protected] (M.M.); [email protected] (D.H.) 3 Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman 15462, Kuwait; [email protected] (P.C.); [email protected] (I.A.-K.); [email protected] (M.A.-F.); [email protected] (J.A.) 4 Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Jabriya 046302, Kuwait; [email protected] * Correspondence: [email protected] (A.A.M.); [email protected] (F.A.-M.); Tel.: +965-2224-2999 (ext. 2805) (A.A.M.); +965-6777-1040 (F.A.-M.) These authors equally contributed to this work. y Received: 5 July 2020; Accepted: 20 August 2020; Published: 24 August 2020 Abstract: Adenylate cyclases (ADCYs) catalyze the conversion of ATP to cAMP,an important co-factor in energy homeostasis. Giving ADCYs role in obesity, diabetes and inflammation, we questioned whether calcium-stimulated ADCY isoforms may be variably detectable in human plasma.
    [Show full text]
  • The Suppressive Role of Mir-542-5P in NSCLC
    He et al. BMC Cancer (2017) 17:655 DOI 10.1186/s12885-017-3646-1 RESEARCH ARTICLE Open Access The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model Rong-quan He1†, Xiao-jiao Li2†, Lu Liang3, You Xie3, Dian-zhong Luo3, Jie Ma3, Zhi-gang Peng3, Xiao-hua Hu1,3* and Gang Chen3* Abstract Background: Non-small cell lung cancer (NSCLC) has led to the highest cancer-related mortality for decades. To enhance the efficiency of early diagnosis and therapy, more efforts are urgently needed to reveal the origins of NSCLC. In this study, we explored the effect of miR-542-5p in NSCLC with clinical samples and in vivo models and further explored the prospective function of miR-542-5p though bioinformatics methods. Methods: A total of 125 NSCLC tissue samples were collected, and the expression of miR-542-5p was detected by qRT-PCR. The relationship between miR-542-5p level and clinicopathological features was analyzed. The effect of miR-542-5p on survival time was also explored with K-M survival curves and Cox’s regression. The effect of miR-542- 5p on the tumorigenesis of NSCLC was verified with a chick chorioallantoic membrane (CAM) model. The potential target genes were predicted by bioinformatics tools, and relevant pathways were analyzed by GO and KEGG. Several hub genes were validated by Proteinatlas. Results: The expression of miR-542-5p was down-regulated in NSCLC tissues, and consistent results were also found in the subgroups of adenocarcinoma and squamous cell carcinoma.
    [Show full text]
  • Loss-Of-Function Variants in ADCY3 Increase Risk of Obesity and Type 2 Diabetes
    BRIEF COMMUNICATION https://doi.org/10.1038/s41588-017-0022-7 Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes Niels Grarup 1, Ida Moltke 2, Mette K. Andersen 1, Maria Dalby2, Kristoffer Vitting-Seerup2,3, Timo Kern1, Yuvaraj Mahendran1, Emil Jørsboe 2, Christina V. L. Larsen4,5, Inger K. Dahl-Petersen4, Arthur Gilly6, Daniel Suveges6, George Dedoussis7, Eleftheria Zeggini 6, Oluf Pedersen1, Robin Andersson 2, Peter Bjerregaard4,5, Marit E. Jørgensen4,5,8*, Anders Albrechtsen 2* and Torben Hansen 1,9* We have identified a variant in ADCY3 (encoding adenylate carriers had type 2 diabetes (P = 7.8 × 10−5; Table 1), while one had cyclase 3) associated with markedly increased risk of obesity impaired fasting glucose and one had impaired glucose tolerance. and type 2 diabetes in the Greenlandic population. The variant Notably, the association with type 2 diabetes remained significant disrupts a splice acceptor site, and carriers have decreased after adjustment for BMI (P = 6.5 × 10−4), suggesting that it is not ADCY3 RNA expression. Additionally, we observe an enrich- simply mediated by increased BMI. The effects on BMI and type 2 ment of rare ADCY3 loss-of-function variants among indi- diabetes were also observed, although with smaller sizes, when data viduals with type 2 diabetes in trans-ancestry cohorts. These were analyzed according to an additive genetic model (Table 1). findings provide new information on disease etiology relevant However, when we compared the recessive and additive models for future treatment strategies. with the full genotype model, we rejected the additive model (BMI, Identification of homozygous loss-of-function mutations in P =​ 0.002; type 2 diabetes, P =​ 0.004) but not the recessive model humans may readily provide information about the biological (BMI, P =​ 0.17; type 2 diabetes, P =​ 0.095).
    [Show full text]
  • Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression S
    Supplemental material to this article can be found at: http://molpharm.aspetjournals.org/content/suppl/2019/04/15/mol.118.115386.DC1 1521-0111/95/6/629–637$35.00 https://doi.org/10.1124/mol.118.115386 MOLECULAR PHARMACOLOGY Mol Pharmacol 95:629–637, June 2019 Copyright ª 2019 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression s Joseph C. Galley, Brittany G. Durgin, Megan P. Miller, Scott A. Hahn, Shuai Yuan, Katherine C. Wood, and Adam C. Straub Heart, Lung, Blood and Vascular Medicine Institute (J.C.G., B.G.D., M.P.M., S.A.H., S.Y., K.C.W., A.C.S.) and Department of Pharmacology and Chemical Biology (J.C.G., A.C.S.), University of Pittsburgh, Pittsburgh, Pennsylvania Received November 29, 2018; accepted March 31, 2019 Downloaded from ABSTRACT Nitric oxide (NO) stimulates soluble guanylyl cyclase (sGC) protein expression showed a concentration-dependent down- activity, leading to elevated intracellular cyclic guano- regulation. Consistent with the loss of sGC a and b mRNA and sine 39,59-monophosphate (cGMP) and subsequent vascular protein expression, pretreatment of vascular smooth muscle smooth muscle relaxation. It is known that downregulation of cells with the FoxO inhibitor decreased sGC activity mea- sGC expression attenuates vascular dilation and contributes to sured by cGMP production following stimulation with an NO molpharm.aspetjournals.org the pathogenesis of cardiovascular disease. However, it is not donor.
    [Show full text]
  • (F1052) Polyclonal Antibody
    PRODUCT DATA SHEET Bioworld Technology,Inc. ADCY 5/6 (F1052) polyclonal antibody Catalog: BS2208 Host: Rabbit Reactivity: Human,Mouse,Rat BackGround: cyclase type 6 protein. A cyclase V, also known as ADCY5, is a 1,261 amino ac- DATA: id Adenylyl cyclase that localizes to cellular membranes and contains two guanylate cyclase domains. Similar to other A cyclase proteins, A cyclase V uses magnesium as a cofactor to catalyze the conversion of ATP to cAMP. A cyclase VI, also known as ADCY6 (adenylate cyclase type 6), is a 1,168 amino acid A cyclase that localizes to the membrane and contains two guanylate cyclase do- mains. Using magnesium as a cofactor, A cyclase VI Western blot (WB) analysis of ADCY 5/6 (F1052) polyclonal antibody functions as a calcium-inhibitable A cyclase that catalyzes at 1:500 dilution the conversion of ATP to 3',5'-cyclic AMP and diphos- Lane1:Panc1 whole cell lysate(40ug) phate and plays a role in a variety of events throughout Lane2:PC3 whole cell lysate(40ug) the body. Multiple isoforms of A cyclase VI exist due to Lane3:HEK293T whole cell lysate(40ug) alternative splicing events. Lane4:Hela whole cell lysate(40ug) Product: Lane5:MCF-7 whole cell lysate(40ug) Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, Lane6:The Pancreas tissue lysate of Mouse(40ug) 50% glycerol, pH7.2 Lane7:The Pancreas tissue lysate of Rat(40ug) Molecular Weight: ~ 130, 139 kDa Swiss-Prot: O95622/O43306 Purification&Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific im- Immunohistochemistry (IHC) analyzes of ADCY 5/6 (F1052) pAb in munogen and the purity is > 95% (by SDS-PAGE).
    [Show full text]
  • Anoctamin 1 - a Member of a Novel Family of Ion Channels with Extended Functions and Significance in Disease
    UNIVERSIDADE DE LISBOA FACULDADE DE CIÊNCIAS Anoctamin 1 - A Member of a Novel Family of Ion Channels with Extended Functions and Significance in Disease Doutoramento em Biologia Especialidade: Biologia de Sistemas Joana Ramos Rapaz Lérias Tese orientada por: Prof. Dr. Karl Kunzelmann e Prof. Dr. Margarida D. Amaral Documento especialmente elaborado para a obtenção do grau de doutor 2018 UNIVERSIDADE DE LISBOA FACULDADE DE CIÊNCIAS Anoctamin 1 - A Member of a Novel Family of Ion Channels with Extended Functions and Significance in Disease Doutoramento em Biologia Especialidade: Biologia de Sistemas Joana Ramos Rapaz Lérias Tese orientada por: Prof. Dr. Karl Kunzelmann e Prof. Dr. Margarida D. Amaral Júri: Presidente: ● Doutor Rui Manuel dos Santos Malhó, Professor Catedrático da Faculdade de Ciências da Universidade de Lisboa Vogais: ● Doutor Karl Kunzelmann, Kunzelmann, Professor, Faculty of Biology and Pre-Clinical Medicine da University of Regensburg, Alemanha (orientador); ● Doutor Ana Colette Pereira de Castro Osório Maurício, Professora Associada com Agregação, Instituto de Ciências Biomédicas Abel Salazar (ICBAS) da Universidade do Porto; ● Doutor Peter Jordan, Investigador Principal, Departamento de Genética Humana do Instituto Nacional de Saúde Doutor Ricardo Jorge; ● Doutora Maria da Graça Tavares Rebelo de Soveral Rodrigues, Professora Associada com Agregação, Faculdade de Farmácia da Universidade de Lisboa. Documento especialmente elaborado para a obtenção do grau de doutor Fundação para a Ciência e Tecnologia do Ministério da Educação e Ciência (FCT/ SFRH / BD / 52489 / 2014) 2018 De acordo com o disposto no artigo 24º do Regulamento de Estudos de Pós- Graduação da Universidade de Lisboa, Despacho nº 7024/2017, publicado no Diário da República – 2ª Série – nº 155 – 11 de Agosto de 2017, foram utilizados nesta dissertação resultados incluídos nos seguintes artigos: 1.
    [Show full text]
  • Whole-Genome DNA Methylation and Hydroxymethylation Profiling for HBV-Related Hepatocellular Carcinoma
    INTERNATIONAL JOURNAL OF ONCOLOGY 49: 589-602, 2016 Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma CHAO YE*, RAN TAO*, QINGYI CAO, DANHUA ZHU, YINI WANG, JIE WANG, JUAN LU, ERMEI CHEN and LANJUAN LI State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, P.R. China Received March 18, 2016; Accepted May 13, 2016 DOI: 10.3892/ijo.2016.3535 Abstract. Hepatocellular carcinoma (HCC) is a common tions between them. Taken together, in the present study we solid tumor worldwide with a poor prognosis. Accumulating conducted the first genome-wide mapping of DNA methyla- evidence has implicated important regulatory roles of epigen- tion combined with hydroxymethylation in HBV-related HCC etic modifications in the occurrence and progression of HCC. and provided a series of potential novel epigenetic biomarkers In the present study, we analyzed 5-methylcytosine (5-mC) for HCC. and 5-hydroxymethylcytosine (5-hmC) levels in the tumor tissues and paired adjacent peritumor tissues (APTs) from Introduction four individual HCC patients using a (hydroxy)methylated DNA immunoprecipitation approach combined with deep Hepatocellular carcinoma (HCC), a common solid tumor, is sequencing [(h)MeDIP-Seq]. Bioinformatics analysis revealed the third most frequent cause of cancer-related death in the that the 5-mC levels in the promoter regions of 2796 genes and world. Hepatitis B virus (HBV) infection is the main cause of the 5-hmC levels in 507 genes differed significantly between HCC in China (1).
    [Show full text]
  • Neomorphic Effects of Recurrent Somatic Mutations in Yin Yang 1 in Insulin-Producing Adenomas
    Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas M. Kyle Cromera,b, Murim Choia,b, Carol Nelson-Williamsa,b, Annabelle L. Fonsecac,d,e, John W. Kunstmanc,d,e, Reju M. Korahc,d,e, John D. Overtona,f, Shrikant Manea,f, Barton Kenneyg, Carl D. Malchoffh,i, Peter Stalbergj, Göran Akerströmj, Gunnar Westinj, Per Hellmanj, Tobias Carlingc,d,e, Peyman Björklundj, and Richard P. Liftona,b,f,k,1 Departments of aGenetics, cSurgery, gPathology, and kInternal Medicine, bHoward Hughes Medical Institute, dYale Endocrine Neoplasia Laboratory, eYale Cancer Center, and fYale Center for Genome Analysis, Yale University School of Medicine, New Haven, CT 06510; hDivision of Endocrinology and iNeag Cancer Center, University of Connecticut Health Center, Farmington, CT 06030; and jDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden 751 05 Contributed by Richard P. Lifton, February 25, 2015 (sent for review January 15, 2015; reviewed by Mitchell A. Lazar and Vamsi K. Mootha) Insulinomas are pancreatic islet tumors that inappropriately secrete provides the basis for the clinical efficacy of GLP-1 and inhibitors insulin, producing hypoglycemia. Exome and targeted sequencing of dipeptidyl peptidase 4, which normally degrades GLP-1; these revealed that 14 of 43 insulinomas harbored the identical somatic drugs increase glucose-dependent insulin secretion and lower mutation in the DNA-binding zinc finger of the transcription fac- blood glucose (10). + tor Yin Yang 1 (YY1). Chromatin immunoprecipitation sequencing Sustained elevations in both intracellular Ca2 and GLP-1 sig- (ChIP-Seq) showed that this T372R substitution changes the DNA naling are known to also promote proliferation of β-cells (11, 12).
    [Show full text]
  • Protein Family Members. the GENE.FAMILY
    Table 3: Protein family members. The GENE.FAMILY col- umn shows the gene family name defined either by HGNC (superscript `H', http://www.genenames.org/cgi-bin/family_ search) or curated manually by us from Entrez IDs in the NCBI database (superscript `C' for `Custom') that we have identified as corresonding for each ENTITY.ID. The members of each gene fam- ily that are in at least one of our synaptic proteome datasets are shown in IN.SYNAPSE, whereas those not found in any datasets are in the column OUT.SYNAPSE. In some cases the intersection of two HGNC gene families are needed to specify the membership of our protein family; this is indicated by concatenation of the names with an ampersand. ENTITY.ID GENE.FAMILY IN.SYNAPSE OUT.SYNAPSE AC Adenylate cyclasesH ADCY1, ADCY2, ADCY10, ADCY4, ADCY3, ADCY5, ADCY7 ADCY6, ADCY8, ADCY9 actin ActinsH ACTA1, ACTA2, ACTB, ACTC1, ACTG1, ACTG2 ACTN ActininsH ACTN1, ACTN2, ACTN3, ACTN4 AKAP A-kinase anchoring ACBD3, AKAP1, AKAP11, AKAP14, proteinsH AKAP10, AKAP12, AKAP17A, AKAP17BP, AKAP13, AKAP2, AKAP3, AKAP4, AKAP5, AKAP6, AKAP8, CBFA2T3, AKAP7, AKAP9, RAB32 ARFGEF2, CMYA5, EZR, MAP2, MYO7A, MYRIP, NBEA, NF2, SPHKAP, SYNM, WASF1 CaM Endogenous ligands & CALM1, CALM2, EF-hand domain CALM3 containingH CaMKK calcium/calmodulin- CAMKK1, CAMKK2 dependent protein kinase kinaseC CB CalbindinC CALB1, CALB2 CK1 Casein kinase 1C CSNK1A1, CSNK1D, CSNK1E, CSNK1G1, CSNK1G2, CSNK1G3 CRHR Corticotropin releasing CRHR1, CRHR2 hormone receptorsH DAGL Diacylglycerol lipaseC DAGLA, DAGLB DGK Diacylglycerol kinasesH DGKB,
    [Show full text]